Houston, TX, United States of America

Joe Marszalek

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 7.1

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Houston, TX (US) (2015 - 2019)
  • Katy, TX (US) (2021)

Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Joe Marszalek: Innovator in HIF Modulation

Introduction

Joe Marszalek is an accomplished inventor based in Houston, Texas, recognized for his innovative contributions to cancer treatment through his work on HIF (hypoxia-inducible factor) modulation. With a total of five patents to his name, Marszalek continues to push the boundaries of medical science, particularly in the area of hypoxia-mediated diseases.

Latest Patents

His recent patents include groundbreaking research on "Heterocyclic modulators of HIF activity for treatment of disease." This invention encompasses compounds and methods designed to inhibit HIF pathway activity, offering new avenues for the treatment or prevention of cancer and other diseases influenced by hypoxia. Such innovations represent significant advancements in therapeutic strategies for cancer management.

Career Highlights

Marszalek is currently affiliated with the University of Texas System, where he leverages his expertise to drive forward significant research initiatives. His work not only showcases his innovative spirit but also emphasizes the importance of academic institutions in the realm of scientific discovery.

Collaborations

Throughout his career, Marszalek has collaborated with esteemed colleagues, including Philip Jones and Alessia Petrocchi. These collaborations enhance the research environment, fostering a sharing of ideas and expertise that leads to the development of novel therapeutic approaches.

Conclusion

Joe Marszalek stands out as an influential figure in the field of medical research, with a keen focus on HIF modulation for cancer treatment. His patents reflect significant scientific achievements, and his ongoing work at the University of Texas System ensures that he remains at the forefront of innovation in the fight against hypoxia-mediated diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…